-
Patient and Doctor Partnerships
As more cancer patients take an interest in the science of their care, it’s vital to establish good relationships with doctors.
by Karon Warren
-
Exploring a New Frontier
AACR patient advocate forum addresses developments in cancer early detection tests.
by Thomas Celona
-
Forward Look
A New Breast Cancer SubtypeClinical trial results are changing care for people with metastatic breast cancer that expresses low levels of HER2 protein.
by Kris Conner
-
Cancer and Alcohol
Lowering and increasing alcohol consumption is associated with changes in cancer risk.
by Teresa Bergen
-
Grapefruit: The Healthy Fruit With a Potentially Dangerous Downside
The health benefits of grapefruit are well known, but cancer patients should be aware of potentially harmful interactions it can have with common medicines.
by Anne Danahy
-
Thinking Outside the Clinic
Researchers highlight need for outreach and educational programs to address survivorship disparities.
by Thomas Celona
-
Cultural Competence in the Community
Researchers describe their efforts to understand and improve cancer screening and treatment among underserved populations.
by Kevin McLaughlin
-
Working Toward the End of Cancer Health Disparities
AACR conference explores the science of cancer disparities and what needs to be done to improve cancer outcomes for all people.
by Eric Fitzsimmons
-
Chemotherapy Linked to Hearing Loss in Adults
Get your hearing checked periodically if you will be undergoing chemotherapy with neurotoxic effects.
by Sandra Gordon
-
The View From a CAR T-Cell Clinical Trial
After exhausting her treatment options, Ellen Reich got CAR T-cell treatment for multiple myeloma through a clinical trial.
by Pamela Rafalow Grossman
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles